38 / 88
38
Scientific Programme /
Tuesday, 20 June 2017
WFSBP 2017
TUE
aa
Tuesday, 20 June 2017
T43: SCHIZOPHRENIA: BASIC/ CLINICAL
S-30
SYMPOSIUM
08:30–10:00
Auditorium 15
Recent insights in schizophrenia physiopathology and
treatments
Chair:
Pierre-Michel Llorca, France
Co-Chair: Fabrice Berna, France
001
Bridging the gap between research and clinical
practice: The development of a national network of
schizophrenia expert centers
Fabrice Berna, France
G. Fond
002
Schizophrenia pathophysiology: Recent insights
from neuroimaging on glutamatergic and neuroinflam-
matory mechanisms
Oliver Howes, United Kingdom
003
The influence of hormones on schizophrenia
Iris Sommer, The Netherlands
004
Novel adjunctive therapy approaches for inflam-
matory disturbances in psychiatric disorders
Michael Berk, Australia
T43: SCHIZOPHRENIA: BASIC/ CLINICAL
S-31
SYMPOSIUM
08:30–10:00
Congress Hall A 3
Duration of untreated psychosis: From neuroimaging
to clinical trials
Chair:
John Kane, USA
Co-Chair: Erika Jaaskelainen, Finland
001
Is DUP a moderator of effectiveness with compre-
hensive specialty care in first episode schizophrenia?
John Kane, USA
002
The impact of DUP on short and long term out-
comes in schizophrenia
Erika Jaaskelainen, Finland
003
Is there a relationship between DUP and brain
structure?
Aristotle Voineskos, Canada
004
MRI resting state functional connectivity and DUP
Deepak Sarpal, USA
T47: STIMULATION METHODS (ECT, TMS, VNS, DBS)
S-32
SYMPOSIUM
08:30–10:00
Auditorium 12
New perspectives on transcranial magnetic stimulation
in psychiatric disorders
Chair:
Shinsuke Kito, Japan
Co-Chair: Motoaki Nakamura, Japan
001
Transcranial magnetic stimulation in the treatment
of bipolar depression
Shinsuke Kito, Japan
002
Clinical application of Quadripulse Stimulation
(QPS) to major depression
Motoaki Nakamura, Japan
003
Neurophysiological correlates of various trans-
cranial magnetic stimulation paradigms in patients with
psychiatric disorders: In search of novel biomarkers
Yoshihiro Noda, Japan
004
Combination of computerized cognitive remedia-
tion and transcranial magnetic stimulation
Akihiro Takamiya, Japan
T11: DEPRESSION: BASIC/ CLINICAL
S-33
SYMPOSIUM
08:30–10:00
Auditorium 10
Epigenetic biomarkers for the diagnosis of mood
disorders
Chair:
Tetsuro Ohmori, Japan
Co-Chair: Lourdes Fañanás, Spain
001
DNA methylation profiles of the Brain-derived
Neurotrophic Factor (BDNF) gene as a potent diag-
nostic biomarker in major depression
Manabu Fuchikami, Japan
002
Antenatal prediction of postpartum depression
with blood DNA methylation biomarkers
Zachary Kaminsky, USA
003
Blood diagnostic biomarkers for major depressive
disorder using multiplex DNA methylation profiles
Shusuke Numata, Japan
004
Differential methylation and variable methylation
in depression: A genome-wide analysis of monozygotic
twins
Aldo Cordova-Palomera, Spain